Learning health systems, clinical equipoise and the ethics of response adaptive randomisation

Journal of Medical Ethics

Volumn 44, Issue 6, 2018, Pages 409-415

  London, Alex John ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONCEPTION; EQUIPOISE; HUMAN; HUMAN EXPERIMENT; LEARNING; RANDOMIZATION; REST; CONFLICT; ETHICS; MORALITY; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DISSENT AND DISPUTES; HUMANS; LEARNING HEALTH SYSTEM; MORAL OBLIGATIONS; PROFESSIONAL ROLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THERAPEUTIC EQUIPOISE;

EID: 85051582270     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2017-104549     Document Type: Article

References (35)

1. Institute of Medicine. Rewarding provider performance: aligning incentives in medicare, pathways to quality health care. Washington, DC: The National Academies Press, 2007.
2. Renfro LA, Sargent DJ. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples. Ann Oncol 2017;28:34-43.
3. Trusheim MR, Shrier AA, Antonijevic Z, et al. PIPELINEs: creating comparable clinical knowledge efficiently by linking trial platforms. Clin Pharmacol Ther 2016;100:713-29.
4. Lewis RJ. The pragmatic clinical trial in a learning health care system. Clin Trials 2016;13:484-92.
5. Berry DA. Adaptive clinical trials: the promise and the caution. J Clin Oncol 2011;29:606-9.
6. Harrington D, Parmigiani G. I-SPY 2-A glimpse of the future of phase 2 drug development. N Engl J Med 2016;375:7-9.
7. Lin J, Lin LA. A General Overview of Adaptive Randomization Design for Clinical Trials. J Biom Biostat 2016;07:294.
8. Meurer WJ, Lewis RJ, Berry DA. Adaptive clinical trials: a partial remedy for the therapeutic misconception. JAMA 2012;307:2377-8.
9. Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials 2016;13:358-66.
10. Freidlin B, Korn EL. Ethics of outcome adaptive randomization. Wiley StatsRef: Statistics Reference Online 2016 (Epub ahead of print: 15 Feb 2016).
11. Lee JJ, Chen N, Yin G. Worth adapting. Revisiting the usefulness of outcome-adaptive randomization. Clin Cancer Res 2012;18:4498-507.
12. Thall P, Fox P, Wathen J. Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials. Ann Oncol 2015;26:1621-8.
13. Hey SP, Kimmelman J. Are outcome-adaptive allocation trials ethical. Clin Trials 2015;12:102-6.
14. Cellamare M, Ventz S, Baudin E, et al. A Bayesian response-adaptive trial in tuberculosis: the endTB trial. Clin Trials 2017;14:17-28.
15. Laage T, Loewy JW, Menon S, et al. Ethical considerations in adaptive design clinical trials. Ther Innov Regul Sci 2017;51:190-9.
16. Saxman SB. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective. Bioethics 2015;29:59-65.
17. Fried C. Medical experimentation: personal integrity and social policy. Amsterdam: North-Holland, 1974.
18. London AJ. Clinical Equipoise: Foundational requirement or fundamental error. Steinbock B, ed. The oxford handbook of bioethics. Oxford, UK: Oxford University Press, 2007:571-95.
19. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5.
20. Kadane JB. Bayesian methods and ethics in a clinical trial design. New York: Wiley, 1996.
21. London AJ. Reasonable risks in clinical research: a critique and a proposal for the Integrative Approach. Stat Med 2006;25:2869-85.
22. London AJ. Two dogmas of research ethics and the integrative approach to humansubjects research. J Med Philos 2007;32:99-116.
23. Thall PF. Ethical issues in oncology biostatistics. Stat Methods Med Res 2002;11:429-48.
24. Lilford RJ, Jackson J. Equipoise and the ethics of randomization. J R Soc Med 1995;88:552-9.
25. Savage LJ. The foundations of statistics. New York: Dover Publications, 1972.
26. Kimmelman J, London AJ. Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med 2011;8:e1001010.
27. Hull DL. Science as a process: an evolutionary account of the social and conceptual development of science. chicago illinois: The University of Chicago Press, 2008.
28. Kitcher P. The advancement of science: science without legend, objectivity without illusions. New York: Oxford University Press, 1995.
29. Solomon M. Scientific rationality and human reasoning. Philos Sci 1992;59:439-55.
30. Muldoon R. Diversity and the division of cognitive labor. Philos Compass 2013;8:117-25.
31. Zollman KJS. The epistemic benefit of transient diversity. Erkenntnis 2010;72:17-35.
32. Miller FG, Brody H. A critique of clinical equipoise: therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep 2003;33:19-28.
33. Eyal N, Lipsitch M. Vaccine testing for emerging infections: the case for individual randomization. J Med Ethics 2017:1-7.
34. Genest C, McConway KJ, Schervish MJ, et al. Characterization of externally Bayesian pooling operators. The Annals of Statistics:314-32.
35. Seidenfeld T, Schervish MJ, Kadane JB. Coherent choice functions under uncertainty. Synthese 2010;172:157-76.